Percutaneous ring repair for leaking tricuspid valve
Part of Heart & circulation clinical trials.
This early study tests a minimally invasive device that helps tighten (repair) the tricuspid valve ring to reduce severe leaking. It may help people who still have symptoms from right-sided heart failure even after taking the best available medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (18+) with moderate-to-severe tricuspid valve leaking confirmed on heart ultrasound (echo)
- Have a sufficiently large tricuspid valve ring size on echo (within the last 90 days)
- Have symptoms of right-sided heart failure even after optimized medical treatment
- Have heart pumping strength that is not too low (LVEF at least 30% on echo within 90 days)
- Have suitable heart/valve anatomy on imaging for this specific device, plus ability to consent and attend follow-ups
- Not have certain high-risk or blocking conditions, like recent serious heart events, blood clots/infection needing treatment, or problems with ultrasound imaging
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new catheter-based device to repair a leaky tricuspid heart valve (tricuspid regurgitation) in people who still have symptoms like shortness of breath or swelling despite taking heart medications. The goal is to see if the procedure is safe and can help reduce the leak.
This trial tests a device called the Pivot Bridge System to treat severe leakage of the tricuspid valve (the valve between the right upper and lower heart chambers). The goal is to see if it safely reduces symptoms like swelling and shortness of breath.
This study tests a new device to fix a leaking tricuspid valve (the valve that helps blood flow from the heart to the lungs) without open-heart surgery. It is for people with severe leaking that causes symptoms like shortness of breath or tiredness, and who are not good candidates for surgery.
This trial studies a catheter-based repair to help fix a leaky tricuspid valve (regurgitation), especially when you’re also having another heart surgery. It aims to improve valve function and symptoms while tracking safety and outcomes.
This trial compares two surgical options (a band versus a ring) to treat tricuspid valve regurgitation, which means blood leaks backward through the tricuspid valve. It may help your heart work more efficiently and reduce symptoms by testing which device works better for people with the right valve problem.
This study tests a clip device to fix a leaky tricuspid valve without open-heart surgery. It may help people who have symptoms like breathlessness or swelling and are not good candidates for surgery.
Hear when a new Tricuspid Regurgitation Functional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.